PARK ROYAL MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: E84645 | LONDON, NW10 7NS
Showing results 51-100 of 573
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lactulose | 505 | 286.7K | £2.7K | +53.4% ▲ |
| Naproxen | 502 | 23.0K | £1.8K | -49.2% ▼ |
| Finasteride | 499 | 11.3K | £428 | -23.8% ▼ |
| Solifenacin | 498 | 14.8K | £1.0K | +4.4% ▲ |
| 490 | 44.8K | £3.2K | +509.0% ▲ | |
| Tramadol hydrochloride | 482 | 32.0K | £1.5K | -32.7% ▼ |
| Allopurinol | 473 | 18.1K | £411 | -54.1% ▼ |
| Vitamin B compound | 469 | 13.7K | £440 | +236.7% ▲ |
| 465 | 6,960 | £5.2K | -30.0% ▼ | |
| Cetirizine hydrochloride | 464 | 49.3K | £2.6K | -7.1% ▼ |
| Isosorbide mononitrate | 460 | 7,790 | £1.4K | -30.4% ▼ |
| 426 | 55.7K | £1.6K | +54.1% ▲ | |
| Famotidine | 424 | 9,205 | £5.4K | -13.1% ▼ |
| Gabapentin | 417 | 55.4K | £4.7K | -58.2% ▼ |
| Bendroflumethiazide | 416 | 13.6K | £234 | -46.2% ▼ |
| Ezetimibe | 412 | 14.2K | £2.4K | -42.1% ▼ |
| Hydrocortisone | 411 | 15.2K | £3.4K | -8.3% ▼ |
| Quetiapine | 409 | 13.5K | £4.9K | -34.3% ▼ |
| Sitagliptin | 408 | 16.2K | £1.2K | +4.6% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 400 | 33.1K | £3.5K | +77.0% ▲ |
| Alginic acid compound preparations | 398 | 254.9K | £2.8K | -32.1% ▼ |
| Baclofen | 394 | 359.7K | £3.8K | +96.7% ▲ |
| Rivaroxaban | 392 | 8,382 | £5.7K | -35.9% ▼ |
| Ibuprofen | 391 | 35.5K | £1.2K | -23.1% ▼ |
| Rosuvastatin calcium | 389 | 12.6K | £409 | -56.7% ▼ |
| Alendronic acid | 387 | 1,952 | £580 | -48.4% ▼ |
| Diclofenac diethyl | 377 | 39.9K | £2.4K | +6.2% ▲ |
| Propranolol hydrochloride | 376 | 25.6K | £1.2K | -64.8% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 365 | 36.0K | £1.5K | +19.1% ▲ |
| Olanzapine | 364 | 9,922 | £1.1K | -1.7% vs avg |
| Prednisolone | 364 | 15.2K | £1.6K | -54.4% ▼ |
| Alfacalcidol | 350 | 12.2K | £2.1K | +183.0% ▲ |
| 336 | 32.1K | £2.2K | +55.3% ▲ | |
| Lisinopril | 334 | 15.2K | £338 | -69.5% ▼ |
| Sodium valproate | 333 | 115.6K | £6.3K | +4.7% ▲ |
| Latanoprost | 333 | 10.1K | £3.0K | -31.4% ▼ |
| Mometasone furoate | 330 | 384 | £3.0K | -17.8% ▼ |
| Irbesartan | 323 | 10.9K | £559 | +32.6% ▲ |
| Candesartan cilexetil | 322 | 12.3K | £515 | -72.9% ▼ |
| Lamotrigine | 317 | 24.1K | £1.9K | -46.3% ▼ |
| Risperidone | 311 | 15.8K | £573 | +22.9% ▲ |
| Insulin aspart | 307 | 1,835 | £11.9K | -19.4% ▼ |
| 304 | 220.5K | £10.8K | +697.4% ▲ | |
| Carbocisteine | 299 | 187.6K | £3.6K | -44.0% ▼ |
| Aripiprazole | 297 | 6,639 | £1.3K | +16.7% ▲ |
| Insulin glargine | 297 | 1,771 | £12.8K | +4.6% ▲ |
| Buprenorphine | 295 | 1,234 | £4.5K | -19.5% ▼ |
| Nebivolol | 290 | 9,324 | £1.5K | +173.6% ▲ |
| Perindopril erbumine | 288 | 11.6K | £990 | -45.7% ▼ |
| Eplerenone | 273 | 4,001 | £512 | +2.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.